► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs<br /><br />Sir Andrew Witty, chief executive of GlaxoSmithKline, talks to the FT's pharmaceuticals correspondent Andrew Ward about a challenging past year for the drugmaker and his strategy for returning it to growth.<br /><br />► FT Business: http://bit.ly/1KUK08s<br /><br />► UK Business & Politics: http://bit.ly/1AXNyGS<br /><br />► SABMiller Looks to craft beer for growth: http://bit.ly/1IyNpLK<br /><br />For more video content from the Financial Times, visit http://www.FT.com/video<br /><br />Twitter https://twitter.com/ftvideo<br />Facebook https://www.facebook.com/financialtimes
